Vitamin D Plus K2: Does the Combination Hold Up?

Walk the supplement aisle of any pharmacy from Kittery to Caribou in January and you’ll notice something. The vitamin D bottles aren’t just vitamin D anymore. More and more of them now read D3 plus K2. There’s a reason the pairing shows up so often this far north, and a reason it’s worth a skeptical second look before you trust the marketing.

Why so many Mainers reach for the bottle

Start with the sun, or the lack of it. Maine sits at roughly 44 to 45 degrees north, far enough from the equator that winter sunlight cannot trigger vitamin D production in the skin. A landmark 1988 study by Holick and colleagues measured this directly in Boston, at 42.2 degrees north and just south of Portland. Skin exposed to midday winter sun produced essentially no previtamin D3 from November through February. The researchers called that stretch the vitamin D winter. Maine is slightly farther north than the study site, so our window is, if anything, a touch longer.

So the supplement habit makes sense. What’s newer is the K2 riding along on the label. If you want a refresher on decoding everything else printed on that bottle, our guide on how to read a supplement label covers the fine print. Here, the question is narrower: does adding K2 earn its place?

What vitamin K2 actually does

Vitamin K is an essential nutrient, and its job inside the body is specific. It works as an enzyme cofactor, switching certain proteins on through a process called carboxylation. According to the NIH Office of Dietary Supplements, that activation is what lets proteins like osteocalcin bind calcium into the bone matrix. No vitamin K, no switch.

There are two main forms. Vitamin K1 (phylloquinone) comes from leafy greens. Vitamin K2 (the menaquinones, including the forms labeled MK-4 and MK-7) shows up in fermented foods and some animal products. Most combination supplements use K2, usually MK-7.

The logic behind pairing it with D goes like this. Vitamin D helps the body absorb calcium from food. Vitamin K then helps put that calcium where it belongs, into bone, and keep it out of where it doesn’t belong, the artery walls. A 2024 review in the journal Nutrients lays out the mechanism: D handles absorption, K activates two different calcium-handling proteins, osteocalcin in bone and matrix Gla protein in blood vessels. The same review notes that taking vitamin D by itself can raise the inactive, uncarboxylated form of matrix Gla protein. That shift is the biological argument supplement makers lean on for adding K2. It’s a tidy theory. The harder question is whether it pays off in trials.

What the bone research shows

Bone density is where the combination has its best evidence, and even there the picture comes with footnotes. A 2022 systematic review and meta-analysis in Frontiers in Medicine pooled 16 randomized controlled trials covering 6,425 participants. Overall, vitamin K2 improved lumbar-spine bone mineral density. But the subgroup breakdown is the part worth reading aloud. The benefit held up when K2 was combined with other nutrients such as vitamin D. K2 taken on its own was not significantly different from the control group.

In other words, the pairing seems to matter. The 2024 Nutrients review reached a similar conclusion for menopausal women: combining D and K may help bone and cardiovascular health more than either vitamin taken alone, though the authors are careful to call the evidence promising rather than settled. Study lengths ran anywhere from four weeks to three years, with different doses and different populations, which makes clean comparisons hard.

One more caveat that matters for anyone shopping in a North American store. Much of the strongest fracture evidence for K2 comes out of Japan and used very high doses of the MK-4 form. The 2022 analysis points out that doses ranged from 45 milligrams a day of one form down to 375 micrograms a day of another, roughly a hundredfold gap. The bottle on your shelf in Bangor is almost certainly nothing like the Japanese trial regimens, so those results don’t transfer neatly.

What the heart research shows

The newest and most interesting evidence is on arteries. In June 2026, JAMA Cardiology published the VitaK-CAC trial. Researchers randomized 167 patients with symptomatic coronary artery disease to either MK-7 or a placebo for two years, then measured the buildup of calcium in their coronary arteries. The K2 group showed slower progression, roughly 29 percent less by one calcium-scoring measure than placebo.

That’s a genuinely encouraging result, and it lines up with a broader pattern. A 2023 meta-analysis in Frontiers in Nutrition pooled 14 trials and found vitamin K significantly slowed coronary artery calcification. But the same analysis is a useful brake on the hype. Of the eight studies looking at calcification in other arteries and heart valves, six found no significant effect. The authors call for more rigorously designed trials.

Here is the line that keeps the VitaK-CAC excitement honest. The trial was not designed to show that K2 prevents heart attacks or deaths. The American College of Cardiology’s summary notes it wasn’t powered for those harder outcomes, and the investigators themselves say more is needed before treating MK-7 as a therapy. A calcium score is a marker on a scan, not an event you live through. Slowing the number is reason to keep studying it, not proof that it saves lives.

The one safety note you shouldn’t skip

If you take a blood thinner such as warfarin, talk to your provider before any supplement containing vitamin K. This isn’t a gentle suggestion. Warfarin works by interfering with how the body recycles vitamin K, and the NIH Office of Dietary Supplements warns that vitamin K decreases the effectiveness of warfarin and similar drugs. A D-plus-K2 combo can quietly work against the medication. People on those drugs are exactly the population a casual aisle purchase could put at risk.

For everyone else, the honest read is this. The pairing has a sound mechanism and decent bone evidence, especially compared to K2 alone, plus one promising new artery trial that still needs harder endpoints. It is not a proven shield against fractures or heart attacks. If you’re weighing the D side of the equation, our comparison of vitamin D3 versus D2 is the better place to start, since getting the D form right is the part research is most confident about. The K2 is a reasonable add, not a miracle, and not for everyone.

Sources

• Holick MF, et al. Influence of season and latitude on the cutaneous synthesis of vitamin D3. Journal of Clinical Endocrinology and Metabolism (PubMed). 1988. https://pubmed.ncbi.nlm.nih.gov/2839537/
• NIH Office of Dietary Supplements. Vitamin K – Health Professional Fact Sheet. 2021. https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/
• Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women. Nutrients (PMC). 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11279569/
• Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine (PMC). 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9403798/
• Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial (VitaK-CAC). JAMA Cardiology. 2026. https://jamanetwork.com/journals/jamacardiology/article-abstract/2850256
• VitaK-CAC: Menaquinone-7 Attenuates CAC in CAD. American College of Cardiology. 2026. https://www.acc.org/latest-in-cardiology/journal-scans/2026/06/15/17/15/vitak-cac
• Vitamin K supplementation and vascular calcification: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition. 2023. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1115069/full

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.